Table 1.
Differential MuD expression and survival correlation revealed by UALCAN and GEPIA.
| Project name | UALCAN | GEPIA | GR(U) | GRG) | S (U) | S (G) | |
|---|---|---|---|---|---|---|---|
| BRCA | Breast invasive carcinoma | N (n = 114) | N (n = 291) | NS | NS | C | No |
| T (n = 1094) | T (n = 1085) | (HL) | |||||
| CHOL | Cholengiocarcinoma | N (n = 9) | N (n = 9) | Up | NS | No | No |
| T (n = 36) | T (n = 36) | ||||||
| COAD | Colon adenocarcinoma | N (n = 41) | N (n = 349) | Down | NS | No | No |
| T (n = 286) | T (n = 275) | ||||||
| DLBC | Lymphoid neoplasm diffuse large B-cell lymphoma | – | N (n = 337) | – | Up | No | No |
| T (n = 47) | |||||||
| ESCA | Esophageal carcinoma | N (n = 11) | N (n = 286) | Up | Up | No | No |
| T (n = 184) | T (n = 182) | ||||||
| GBM | Glioblastoma multiforme | N (n = 5) | N (n = 207) | – | Up | No | No |
| T (n = 156) | T (n = 163) | ||||||
| KICH | Kidney chromophobe | N (n = 25) | N (n = 53) | NS | Up | No | No |
| T (n = 67) | T (n = 66) | ||||||
| KIRC | Kidney renal clear cell carcinoma | N (n = 72) | N (n = 100) | Down | Down | .C | C |
| T (n = 533) | T (n = 523) | (HH) | (HH) | ||||
| KIRP | Kidney renal papillary cell carcinoma | N (n = 32) | N (n = 60) | Down | NS | No | No |
| T (n = 290) | T (n = 286) | ||||||
| LGG | Lower-grade glioma | N (n = 248) | N (n = 207) | NS | Up | No | No |
| T (n = 265) | T (n = 518) | ||||||
| LUAD | Lung adenocarcinoma | N (n = 29) | N (n = 347) | NS | NS | C | No |
| T (n = 519) | T (n = 483) | (HL) | |||||
| OV | Ovarian serous cystadenocarcinoma | – | N (n = 88) | – | Up | No | No |
| T (n = 426) | |||||||
| PAAD | Pancreatic Adenocarcinoma | N (n = 4) | N (n = 171) | NS | Up | No | No |
| T (n = 178) | T (n = 179) | ||||||
| READ | Rectum adenocarcinoma | N (n = 11) | N (n = 92) | Down | NS | No | No |
| T (n = 166) | T (n = 318) | ||||||
| STAD | Stomach adenocarcinoma | N (n = 34) | N (n = 34) | NS | Up | No | No |
| T (n = 415) | T (n = 415) | ||||||
| THYM | Thymoma | N (n = 2) | N (n = 339) | NS | Up | No | No |
| T (n = 120) | T (n = 118) |
Abbreviations of cancer types based on TCGA are given in the left column with project name. UALCAN and GEPIA sample sizes for normal (N) and tumor (T) tissues are indicated for comparison as available or excluded if normal tissue data were unavailable. Gene regulation (GR) upon detection was listed as Up or Down as relevant and according to UALCAN (U) and GEPIA (G). Survival (S) correlation with expression is listed as correlating (C). High expression = Low survival chance (HL) and High expression = High survival chance (HH).